Novonix Stock Number Of Shares Shorted
NVNXF Stock | USD 0.50 0.09 15.25% |
Novonix fundamentals help investors to digest information that contributes to Novonix's financial success or failures. It also enables traders to predict the movement of Novonix Pink Sheet. The fundamental analysis module provides a way to measure Novonix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Novonix pink sheet.
Novonix |
Novonix Company Number Of Shares Shorted Analysis
Novonix's Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
Competition |
Based on the recorded statements, Novonix has 0.0 of outstending shares currently sold short by investors. This is 100.0% lower than that of the Industrials sector and about the same as Electrical Equipment & Parts (which currently averages 0.0) industry. The number of shares shorted for all United States stocks is 100.0% higher than that of the company.
Novonix Number Of Shares Shorted Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Novonix's direct or indirect competition against its Number Of Shares Shorted to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Novonix could also be used in its relative valuation, which is a method of valuing Novonix by comparing valuation metrics of similar companies.Novonix is currently under evaluation in number of shares shorted category among its peers.
Novonix Fundamentals
Return On Equity | -0.26 | |||
Return On Asset | -0.12 | |||
Operating Margin | (7.36) % | |||
Current Valuation | 534.72 M | |||
Shares Outstanding | 485.95 M | |||
Shares Owned By Insiders | 28.18 % | |||
Shares Owned By Institutions | 10.90 % | |||
Price To Book | 2.49 X | |||
Price To Sales | 69.85 X | |||
Revenue | 8.42 M | |||
Gross Profit | 5.41 M | |||
EBITDA | (63.54 M) | |||
Net Income | (71.44 M) | |||
Cash And Equivalents | 207.08 M | |||
Cash Per Share | 0.43 X | |||
Total Debt | 52.15 M | |||
Debt To Equity | 0.17 % | |||
Current Ratio | 20.56 X | |||
Book Value Per Share | 0.75 X | |||
Cash Flow From Operations | (40.35 M) | |||
Earnings Per Share | (0.06) X | |||
Beta | 1.73 | |||
Market Capitalization | 536.98 M | |||
Total Asset | 439.56 M | |||
Z Score | 6.0 | |||
Net Asset | 439.56 M |
About Novonix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Novonix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Novonix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Novonix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Novonix Pink Sheet
Novonix financial ratios help investors to determine whether Novonix Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Novonix with respect to the benefits of owning Novonix security.